Grannus Therapeutics

Biotechnology Research • Indianapolis, Indiana, United States • 1-10 Employees

Company overview

Headquarters	Indianapolis, Indiana, United States
Phone number	+13174146205
Website	grannustherapeutics.com
Founded	2019
Employees	1-10
Socials

Key Contact at Grannus Therapeutics

Sanket Mishra

Co-Founder and VP preclinical R&D

About Grannus Therapeutics

Founded in 2019, Grannus Therapeutics is a pre-clinical stage biotechnology company, focused on the development of small molecule inhibitors for specific isoforms of HSP90. Our lead program is focused on the development of a highly selective small molecule inhibitor of HSP90𝛽 for the treatment of multiple types of cancer. With this program, we have successfully engineered a molecule that selectively inhibits HSP90𝛽, potentially delivering the efficacy benefits of previous pan-inhibitors without their toxicity and dosing challenges.

Grannus Therapeutics revenue & valuation

Annual revenue	$256,665
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$821,328
Total funding	$800,000

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Grannus Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore Grannus Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-03-10	9	N/A
2024-02-11	12	$800,000

Funding Insights

$800,000

Total funding amount

$800,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Grannus Therapeutics is located in Indianapolis, Indiana, US.

You can reach Grannus Therapeutics at +13174146205.

Grannus Therapeutics was founded in 2019, making it 7 years old. The company has established itself as a significant player in its industry over this time.

Grannus Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Grannus Therapeutics has raised a total of $800,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Grannus Therapeutics

Sanket Mishra

Co-Founder and VP preclinical R&D

4.8

40,000 users